Ítem
Solo Metadatos
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders
dc.creator | Ram, Maya | spa |
dc.creator | Anaya, Juan-Manuel | spa |
dc.creator | Barzilai, Ori | spa |
dc.creator | Izhaky, David | spa |
dc.creator | Katz, Bat-sheva Porat | spa |
dc.creator | Blank, Miri | spa |
dc.creator | Shoenfeld, Yehuda | spa |
dc.date.accessioned | 2020-05-26T00:01:22Z | |
dc.date.available | 2020-05-26T00:01:22Z | |
dc.date.created | 2008 | spa |
dc.description.abstract | Background: The etiology of autoimmune diseases is not fully clarified and the mechanisms underlying their initiation and progression are still obscure. It is becoming clear that in a genetic susceptible individual an environmental trigger such as infectious agent in general and viruses in particular could initiate the development of an autoimmune disease. Hepatitis B virus (HBV) is notorious in its association with diverse autoimmune diseases. Therefore, we aimed to determine the presence of hepatitis B core antibody (HBcAb), a seromarker for past or present infection with HBV, in a large number of sera collected from patients with different autoimmune diseases. Methods: A cohort of 675 sera samples of 5 different autoimmune diseases and healthy donors were screened for evidence of a prior infection with HBV. All samples were tested for hepatitis B core antibody (IgG) using the Monolisa anti-HBc PLUS commercial kit (Bio-Rad, Hercules, San Francisco, USA). Results: Lower percentage of HBcAb was found in sera of the autoimmune diseases when compared to normal controls. Fifteen (10.7%) from 140 normal controls were found positive for the presence of HBcAb. Two (2%) out of 98 multiple sclerosis (MS) sera were positive for the presence of HBcAb (OR: 0.17, 95%CI: 0.03-0.77, p = 0.01), 3 (2.5%) out of 117 systemic lupus erythematosus (SLE) sera (OR: 0.2, 95%CI: 0.06-0.77, p = 0.01), 4 (4.5%) out of 89 type 1 diabetes (T1D), 5 (6.1%) from 82 Sjogren's syndrome (SS) sera and 12 (8%) from 149 rheumatoid arthritis (RA) sera were positive for the presence of HBcAb. Conclusions: Our data divulge an unexpected low percentage of antibodies to HBcAg in patients with SLE, MS and T1D in comparison to healthy matched donors. This finding may raise a protective role to HBV in some autoimmune diseases i.e. hygiene theory. © 2008 Elsevier B.V. All rights reserved. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1016/j.autrev.2008.06.008 | |
dc.identifier.issn | 15689972 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23356 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 625 | |
dc.relation.citationIssue | No. 8 | |
dc.relation.citationStartPage | 621 | |
dc.relation.citationTitle | Autoimmunity Reviews | |
dc.relation.citationVolume | Vol. 7 | |
dc.relation.ispartof | Autoimmunity Reviews, ISSN:15689972, Vol.7, No.8 (2008); pp. 621-625 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-50949126626&doi=10.1016%2fj.autrev.2008.06.008&partnerID=40&md5=3f5a41252f3bec9c3ffb3ce8809df214 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Hepatitis B core antibody | spa |
dc.subject.keyword | Immunoglobulin G | spa |
dc.subject.keyword | Anamnesis | spa |
dc.subject.keyword | Antibody blood level | spa |
dc.subject.keyword | Autoimmune disease | spa |
dc.subject.keyword | Blood sampling | spa |
dc.subject.keyword | Cohort analysis | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Hepatitis B | spa |
dc.subject.keyword | Hepatitis B virus | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Insulin dependent diabetes mellitus | spa |
dc.subject.keyword | Major clinical study | spa |
dc.subject.keyword | Multiple sclerosis | spa |
dc.subject.keyword | Review | spa |
dc.subject.keyword | Rheumatoid arthritis | spa |
dc.subject.keyword | Screening test | spa |
dc.subject.keyword | Sjoegren syndrome | spa |
dc.subject.keyword | Systemic lupus erythematosus | spa |
dc.subject.keyword | Autoimmune Diseases | spa |
dc.subject.keyword | Hepatitis B | spa |
dc.subject.keyword | Hepatitis B Antibodies | spa |
dc.subject.keyword | Hepatitis B virus | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Autoimmunity | spa |
dc.subject.keyword | Hepatitis B core antibody (hbcab) | spa |
dc.subject.keyword | Hepatitis B virus (HBV) | spa |
dc.subject.keyword | Multiple sclerosis (MS) | spa |
dc.subject.keyword | Rheumatoid arthritis (RA) | spa |
dc.subject.keyword | Sjogren's syndrome (SS) | spa |
dc.subject.keyword | Systemic lupus erythematosus (SLE) | spa |
dc.subject.keyword | Type 1 diabetes (T1D) | spa |
dc.title | The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |